Grishin D, Gusev A. Allelic imbalance of chromatin accessibility in cancer identifies candidate causal risk variants and their mechanisms. Nat Genet. 2022;54(6):837-849. doi:10.1038/s41588-022-01075-2.
Juge P-A, Lee JS, Ebstein E, et al. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. N Engl J Med. 2018;379(23):2209-2219. doi:10.1056/NEJMoa1801562.
Ding M, Ellervik C, Huang T, et al. Diet quality and genetic association with body mass index: results from 3 observational studies. Am J Clin Nutr. 2018;108(6):1291-1300. doi:10.1093/ajcn/nqy203.
Zwakenberg SR, Remmelzwaal S, Beulens JWJ, et al. Circulating Phylloquinone Concentrations and Risk of Type 2 Diabetes: A Mendelian Randomization Study. Diabetes. 2019;68(1):220-225. doi:10.2337/db18-0543.
De Jager PL, Yang H-S, Bennett DA. Deconstructing and targeting the genomic architecture of human neurodegeneration. Nat Neurosci. 2018;21(10):1310-1317. doi:10.1038/s41593-018-0240-z.
Powe CE, Nodzenski M, Talbot O, et al. Genetic Determinants of Glycemic Traits and the Risk of Gestational Diabetes Mellitus. Diabetes. 2018;67(12):2703-2709. doi:10.2337/db18-0203.
Mahajan A, Taliun D, Thurner M, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50(11):1505-1513. doi:10.1038/s41588-018-0241-6.